Disc Medicine (IRON) Accounts Payables (2020 - 2026)

Disc Medicine (IRON) has reported Accounts Payables for 7 consecutive years, with $6.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Accounts Payables rose 7.72% year-over-year to $6.8 million; the TTM figure through Jun 2026 stood at $6.8 million (up 7.72% YoY), while the FY2025 annual figure was $9.0 million, up 13.46% from the prior year.
• Accounts Payables slipped to $6.8 million in Q2 2026 per IRON's latest filing, from $11.8 million in the prior quarter.
• Across five years, Accounts Payables topped out at $16.2 million in Q4 2022 and bottomed at $1.1 million in Q3 2022.
• Historically, Accounts Payables has averaged $7.0 million across 5 years, with a median of $6.5 million in 2025.
• Annual changes were most pronounced in 2023 — Accounts Payables surged 645.92% — and 2024, when it sank 58.18%.
• Disc Medicine's Accounts Payables stood at $16.2 million in 2022, then declined by 21.86% to $12.6 million in 2023, then slumped by 37.07% to $7.9 million in 2024, then grew by 13.46% to $9.0 million in 2025, then decreased by 24.15% to $6.8 million in 2026.
• Business Quant data shows IRON's Accounts Payables at $6.8 million in Q2 2026, $11.8 million in Q1 2026, and $9.0 million in Q4 2025.